Article info
PDFLetter
High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)
- Correspondence to Dr Marco Gattorno, UO Pediatria 2, G Gaslini Institute, Largo G Gaslini 5, Genova, Italy; marcogattorno{at}gaslini.org
Citation
High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)
Publication history
- Received May 16, 2017
- Revised August 8, 2017
- Accepted August 10, 2017
- First published September 2, 2017.
Online issue publication
October 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.